New weight-loss pill hits the market, promising 'greater flexibility'

Following Wegovy’s recent launch of the first oral glucagon-like peptide-1 (GLP-1) medication, another weight-loss pill has been approved by the FDA.

Foundayo (orforglipron) is a once-daily pill developed by Lilly for lasting weight loss. It is reportedly the only type that can be taken at any time of day without food or water restrictions.

Clinical trial participants who took Foundayo lost an average of 27.3 pounds (12.4%) on the highest dose, according to a press release from Lilly.